Overcoming tumor resistance to chemotherapy drugs has long been a challenge for oncology clinicians and researchers. Now, a new study suggests that blocking a key protein, p300, may force damaged ...

Findings showed Orca-T statistically significantly improved survival free of moderate to severe cGvHD vs alloHSCT at 1 year. The Food and Drug Administration (FDA) has accepted for Priority Review the ...

A study led by UC San Francisco and UC Davis has concluded that radiation from medical imaging is associated with a higher risk of blood cancers in children. The researchers examined data from nearly ...

A study led by UC San Francisco and UC Davis has concluded that radiation from medical imaging is associated with a higher risk of blood cancers in children. The researchers examined data from nearly ...

Assessing the risk of radiation-induced hematologic cancer from medical imaging in children and adolescents might support informed decisions on the use of imaging. We followed a retrospective cohort ...

A study led by UC San Francisco and UC Davis has concluded that radiation from medical imaging is associated with a higher risk of blood cancers in children. The researchers examined data from nearly ...

Hematologic malignancy patients face high COVID-19 risk, with 23.5% experiencing severe illness despite vaccination. Mortality rate was 22.4%, influenced by age, active disease, and ICU admission.

Skysona will now only be indicated for patients without an available HLA-matched allogeneic hematopoietic stem cell donor. The Food and Drug Administration (FDA) has approved new safety labeling ...

We conducted a retrospective cohort study at The University of Utah and University of Wisconsin-Madison. Cancer genetics registries were reviewed to identify all unrelated families with LFS seen ...

Dr. Raajit K. Rampal and Dr. Joshua K. Sabari walk through updates for patients in the treatment of blood cancers, including polycythemia vera. There were several notable updates to have come out of ...